116 related articles for article (PubMed ID: 2271816)
21. Spontaneous splenic rupture in atypical (Philadelphia chromosome negative) chronic myeloid leukaemia following blastic crisis.
Sachithanandan A; Gleadhill I; Alexander HD; Morris TC
Ir Med J; 2003 Jun; 96(6):181-2. PubMed ID: 12926761
[TBL] [Abstract][Full Text] [Related]
22. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
[TBL] [Abstract][Full Text] [Related]
23. Extramedullary chronic myelogenous leukaemia mimicking carcinoma colon.
Rusia U; Adiga BK; Madan N; Sikka M; Sharma S; Arora VK
J Indian Med Assoc; 1994 Nov; 92(11):376-7. PubMed ID: 7890946
[No Abstract] [Full Text] [Related]
24. Acute bilineage leukemia after chronic myelogenous leukemia.
Williams SR; Wellhausen SR; Barker RL; Janckila AJ
J Ky Med Assoc; 1997 Sep; 95(9):393-6. PubMed ID: 9322413
[TBL] [Abstract][Full Text] [Related]
25. [Immunophenotype of blast crisis in chronic myeloid leukemia].
Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
[TBL] [Abstract][Full Text] [Related]
26. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
[TBL] [Abstract][Full Text] [Related]
27. [Transformation of Waldenström disease into chronic myeloid leukemia].
Bonanni G; D'Ambrosio F; Marino S; Sindici G; Ieraci A; D'Artista D
Recenti Prog Med; 1999 Oct; 90(10):527-9. PubMed ID: 10592738
[TBL] [Abstract][Full Text] [Related]
28. [Lymph node involvement as a primary localization of extramedullary blast crisis of chronic granulocytic leukemia (PBS)].
Kuliszkiewicz-Janus M; Haus O
Acta Haematol Pol; 1993; 24(1):65-70. PubMed ID: 8488739
[TBL] [Abstract][Full Text] [Related]
29. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
30. CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid.
Bornhauser M; Jenke A; Freiberg-Richter J; Radke J; Schuler US; Mohr B; Ehninger G; Schleyer E
Ann Hematol; 2004 Jun; 83(6):401-2. PubMed ID: 14673623
[TBL] [Abstract][Full Text] [Related]
31. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
32. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
Chen Z; Wang W; Cortes JE; Liu E; Miranda RN; Zhao C; Yuan J; Lu X; Yang W; Ameri MD; Kantarjian HM; Medeiros LJ; Hu S
Blood Cancer J; 2016 May; 6(5):e418. PubMed ID: 27152845
[No Abstract] [Full Text] [Related]
33. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
34. Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy.
Alimena G; Breccia M; Latagliata R; Carmosino I; Russo E; Biondo F; Diverio D; Mancini M; Nanni M; Mandelli F
Cancer; 2006 Sep; 107(5):1008-13. PubMed ID: 16878324
[TBL] [Abstract][Full Text] [Related]
35. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
[TBL] [Abstract][Full Text] [Related]
36. Destructive bone lesions in chronic granulocytic leukemia.
Kumar L; Majhi U; Shanta V
Indian J Cancer; 1990 Dec; 27(4):208-10. PubMed ID: 2090575
[TBL] [Abstract][Full Text] [Related]
37. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
38. Blast crisis in chronic myeloid leukaemia.
Parikh PM; Karandikar SM; Pahuja R; Saikia T; Gopal R; Advani SH
J Assoc Physicians India; 1988 Feb; 36(2):181-2. PubMed ID: 3182655
[No Abstract] [Full Text] [Related]
39. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot G; Weber G
Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
[TBL] [Abstract][Full Text] [Related]
40. [Bone marrow chromosomes in 172 patients with chronic myeloid leukemia].
Michalová K; Musilová J; Jarosová M; Indrák K; Koudelová Z
Vnitr Lek; 1988 Jul; 34(7):694-700. PubMed ID: 3176359
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]